Biotricity Current Deferred Revenue from 2010 to 2026
| BTCY Stock | USD 0.28 0.02 6.67% |
Current Deferred Revenue | First Reported 2015-06-30 | Previous Quarter 475.6 K | Current Value 1.9 M | Quarterly Volatility 740.9 K |
Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 6.3 M or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0035 or Days Sales Outstanding of 141. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
Biotricity | Current Deferred Revenue | Build AI portfolio with Biotricity Stock |
Latest Biotricity's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Biotricity over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Biotricity's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biotricity's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Biotricity Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 560,676 | |
| Geometric Mean | 142,609 | |
| Coefficient Of Variation | 127.42 | |
| Mean Deviation | 658,179 | |
| Median | 139,218 | |
| Standard Deviation | 714,394 | |
| Sample Variance | 510.4B | |
| Range | 1.6M | |
| R-Value | 0.23 | |
| Mean Square Error | 515.1B | |
| R-Squared | 0.05 | |
| Significance | 0.37 | |
| Slope | 32,810 | |
| Total Sum of Squares | 8.2T |
Biotricity Current Deferred Revenue History
About Biotricity Financial Statements
Biotricity investors use historical fundamental indicators, such as Biotricity's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 29.1 K | 27.7 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biotricity Stock Analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.